TRDA — Entrada Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Entrada Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	39	291	189	352	420
Net Total Receivables	—	—	—	5.88	3.68
Prepaid Expenses
Total Current Assets	39.9	299	210	370	440
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.04	6.26	33	92.7	82
Other Long Term Assets
Total Assets	43.5	306	252	469	526
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.36	6.72	22	159	39.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.36	7.12	39.5	227	97.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	40.2	299	213	242	429
Total Liabilities & Shareholders' Equity	43.5	306	252	469	526
Total Common Shares Outstanding